Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ryosuke Taiji

10PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesPredictive and prognostic markersCell physiologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Dec 24, 2025
Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Kiyoyuki Minamiguchi, Mariko Irizato, Ryota Nakano

|Jul 31, 2025
Thoracic Vascular Anomalies: Insights from Embryology and Imaging.

Ryosuke Taiji, Aya Yamada, Katsutoshi Horiuchi

|Feb 06, 2025
Hepatobiliary and Pancreatic Neoplasms: Essential Predictive Imaging Features for Personalized Therapy.

Mariko Irizato, Kiyoyuki Minamiguchi, Tomoko Uchiyama

|Jun 27, 2024
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.

Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri

|May 11, 2024
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji

|Mar 28, 2024
Pictorial Review of Pleural Disease: Multimodality Imaging and Differential Diagnosis.

Aya Yamada, Ryosuke Taiji, Yuko Nishimoto

Pageof 2

Frequent Collaborators

6 joint publications

Kiyoyuki Minamiguchi

6 joint publications

Tetsuya Tachiiri

5 joint publications

Hideki Kunichika

5 joint publications

Toshihiro Tanaka

3 joint publications

Satoshi Yamauchi

2 joint publications

Aya Yamada

1 joint publications

Satoshi Yasuda

1 joint publications

Rony Avritscher

1 joint publications

Rahul A Sheth

1 joint publications

A Kyle Jones

Frequent Collaborators

6 joint publications

Kiyoyuki Minamiguchi

6 joint publications

Tetsuya Tachiiri

5 joint publications

Hideki Kunichika

5 joint publications

Toshihiro Tanaka

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.0K
A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on : Dec 16, 2022

2.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on : Oct 10, 2018

8.2K
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.0K
A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on : Dec 16, 2022

2.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on : Oct 10, 2018

8.2K
See more related videos